07/30/2025
3:33 PM | Brackmann Christoph (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
6:01 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2025
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
12:42 PM | Capital International Investors (Filed by)
NovoCure (Subject)
| Form SCHEDULE 13G/A | |
06/06/2025
3:26 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:13 PM | NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:14 PM | Hung David (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | NovoCure (Issuer)
Scannell Timothy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:16 PM | NovoCure (Issuer)
Ocean Allyson J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:17 PM | HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:19 PM | Madden Martin J. (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NVCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. |
06/04/2025
3:26 PM | NovoCure (Issuer)
Stafford Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:25 PM | Leonard Frank X (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
5:05 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:17 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
6:01 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
7:00 PM | BlackRock, Inc. (Filed by)
NovoCure (Subject)
| Form SCHEDULE 13G/A | |
04/22/2025
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:01 AM | NovoCure (Filer)
| Form DEF 14A | |
04/21/2025
6:02 AM | NovoCure (Filer)
| Form DEFA14A | |
04/01/2025
4:00 PM | NovoCure (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SCHEDULE 13G | |
03/06/2025
3:40 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:41 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:41 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:41 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:42 PM | Ben Arye Barak (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:42 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:48 PM | Brackmann Christoph (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
8:27 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4/A | |
03/03/2025
8:26 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4/A | |
03/03/2025
8:26 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4/A | |
03/03/2025
8:26 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4/A | |
03/03/2025
8:26 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4/A | |
03/03/2025
8:26 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4/A | |
03/03/2025
4:31 PM | NovoCure (Subject)
Paravasthu Mukund (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:34 PM | Leonard Frank X (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:01 PM | NovoCure (Subject)
Weinberg Uri (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:43 PM | Cordova Ashley (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:50 PM | NovoCure (Subject)
Paravasthu Mukund (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:36 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
02/27/2025
6:01 AM | NovoCure (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:05 AM | NovoCure (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/15/2025
3:23 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:28 PM | NovoCure (Subject)
Paravasthu Mukund (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:27 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:00 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:05 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
5:21 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access Sale